MANGOCEUTICALS, INC.
MGRXNasdaq
$0.41
↑ +6.1%Jul 17 close · end-of-day
Price
1Y↓ -71.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.8M
Enterprise Value
$6.6M
P/E
—
P/S
16.4
P/B
0.5
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$414,579.00
Net Income (TTM)
-$19.2M
Free Cash Flow (TTM)
—
Gross Margin
52.4%
Operating Margin
-3999.8%
Net Margin
-4632.8%
ROE
-142.5%
ROIC
-98.5%
Debt / Equity
—
Net Cash
$174,562.00
Return 1Y
-73.9%
Company profile
We plan to connect consumers to licensed healthcare professionals through our recently launched website at www.MangoRX.com for the provision of care via telehealth on our customer portal and plan to also provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. Our principal executive offices are located in Dallas, Texas.
- CEO
- Jacob D. Cohen
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- Texas
- Website
- www.mangorx.com
Management & directors
- Johnston Eugene MChief Financial Officer
- Cohen Jacob D.Chief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
MGRX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$67,864.00↓ -37.9%
Diluted EPS-$0.22↓ -80.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8,939.00 | $731,493.00 | $615,873.00 | $456,021.00 |
| Gross profit | $4,850.00 | $431,501.00 | $379,964.00 | $250,386.00 |
| Operating income | -$2.0M | -$9.2M | -$8.0M | -$18.0M |
| Net income | -$2.0M | -$9.2M | -$8.7M | -$20.6M |
| Diluted EPS | -$0.19 | -$8.58 | -$4.80 | -$2.17 |
| Operating cash flow | -$1.3M | -$7.0M | -$4.9M | -$5.9M |
| Free cash flow | -$1.4M | -$7.0M | — | — |
| Gross margin | 54.3% | 59.0% | 61.7% | 54.9% |
| Operating margin | -22279.7% | -1260.3% | -1294.4% | -3954.3% |
| Net margin | -22352.1% | -1259.4% | -1413.6% | -4526.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $163,163.00 | $133,368.00 | $105,247.00 | $109,306.00 | $168,109.00 | $84,246.00 | $94,360.00 | $67,864.00 |
| Gross profit | $69,792.00 | $82,671.00 | $80,103.00 | $62,064.00 | $89,948.00 | $50,899.00 | $47,475.00 | $29,001.00 |
| Operating income | -$2.2M | -$1.8M | -$1.7M | -$4.6M | -$5.3M | -$7.5M | -$644,554.00 | -$3.1M |
| Net income | -$2.4M | -$2.0M | -$1.9M | -$4.8M | -$5.4M | -$7.6M | -$2.8M | -$3.4M |
| Diluted EPS | -$1.37 | -$1.14 | -$0.79 | -$1.12 | -$0.57 | -$0.69 | $0.21 | -$0.22 |
| Operating cash flow | -$1.6M | -$1.2M | -$1.1M | -$2.3M | -$1.3M | -$1.2M | -$1.1M | -$1.3M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 42.8% | 62.0% | 76.1% | 56.8% | 53.5% | 60.4% | 50.3% | 42.7% |
| Operating margin | -1329.1% | -1318.2% | -1594.0% | -4186.8% | -3134.0% | -8953.5% | -683.1% | -4606.8% |
| Net margin | -1465.4% | -1499.0% | -1851.2% | -4427.4% | -3221.6% | -9042.8% | -2935.1% | -5014.7% |
Company news
Mar 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-12-15 | JOHNSTON EUGENE M· CFO | Sale | 3,333 | $1.17 | $3,883.94 | filing |
| 2025-12-09 | JOHNSTON EUGENE M· CFO | Sale | 5,000 | $1.20 | $5,975.00 | filing |
| 2025-12-05 | JOHNSTON EUGENE M· CFO | Sale | 10,000 | $1.13 | $11,280.00 | filing |
| 2025-11-19 | Hamilton Alex P. | Sale | 125,000 | $1.22 | $152,875.00 | filing |
| 2025-09-09 | Cohen Jacob D.· Chief Executive Officer | Award | 500,000 | $0.00 | $0.00 | filing |
| 2025-09-09 | JOHNSTON EUGENE M· Chief Financial Officer | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-09-09 | D'Alessio Lorraine Pamela | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-09-09 | Hamilton Alex P. | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-09-09 | MYERS KENNY | Award | 100,000 | $0.00 | $0.00 | filing |
Latest 9 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.